Telemus Capital, LLC Savara Inc Transaction History
Telemus Capital, LLC
- $1.2 Billion
- Q4 2023
A detailed history of Telemus Capital, LLC transactions in Savara Inc stock. As of the latest transaction made, Telemus Capital, LLC holds 25,214 shares of SVRA stock, worth $106,907. This represents 0.01% of its overall portfolio holdings.
Number of Shares
25,214
Previous 25,214
-0.0%
Holding current value
$106,907
Previous $95,000
24.21%
% of portfolio
0.01%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding SVRA
# of Institutions
145Shares Held
147MCall Options Held
280KPut Options Held
798K-
Nea Management Company, LLC Timonium, MD24.5MShares$104 Million9.31% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA14.6MShares$61.8 Million12.01% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA12.4MShares$52.4 Million7.46% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA8.16MShares$34.6 Million1.94% of portfolio
-
Black Rock Inc. New York, NY8.03MShares$34 Million0.0% of portfolio
About Savara Inc
- Ticker SVRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 114,043,000
- Market Cap $484M
- Description
- Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Austin, Texas.